Blue Water Vaccines Presents New Data Supporting Universal Influenza Vaccine Candidate at the World Vaccine Congress 2022 in Washington, DC
21 avr. 2022 08h45 HE
|
Blue Water Vaccines Inc.
CINCINNATI, April 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines, today...
Blue Water Vaccines Announces Closing of $8 Million Private Placement Priced At-the-Market Under Nasdaq Rules
20 avr. 2022 09h25 HE
|
Blue Water Vaccines Inc.
CINCINNATI, April 20, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address...
Blue Water Vaccines Announces $8 Million Private Placement Priced At-the-Market Under Nasdaq Rules
13 avr. 2022 09h30 HE
|
Blue Water Vaccines Inc.
CINCINNATI, April 13, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address...
Blue Water Vaccines Inc to Present at World Vaccine Congress Washington 2022
11 avr. 2022 09h56 HE
|
Blue Water Vaccines Inc.
BWV-101 - Universal Influenza Program: Developing a novel vaccine to protect against all influenza strains using groundbreaking mathematical models and research CINCINNATI, April 11, 2022 (GLOBE...
Blue Water Vaccines Announces Publication in Nano Research Supporting Novel S&P Vaccine Platform Versatility
22 mars 2022 07h00 HE
|
Blue Water Vaccines Inc.
Blue Water Vaccines has exclusive, global licensing rights to Cincinnati Children’s Hospital Medical Center’s novel virus-like particle (VLP) vaccine platform.The data supports BWV’s ongoing...
Blue Water Vaccines Announces Closing of Initial Public Offering
23 févr. 2022 16h51 HE
|
Blue Water Vaccines Inc.
CINCINNATI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the closing...
Blue Water Vaccines Announces Pricing of approximate $20M Initial Public Offering
17 févr. 2022 19h22 HE
|
Blue Water Vaccines Inc.
CINCINNATI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the...